EDGAR Filing Documents for 0000885590-13-000011

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0000885590-13-000011

Filing Date

2013-02-05

Accepted

2013-02-05 18:04:04

Documents

Period of Report

2013-02-01

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4/A
1	PRIMARY DOCUMENT	primary_doc.xml	4/A	4500
	Complete submission text file	0000885590-13-000011.txt		6073

Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9

Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792

Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 PARSONS POND DRIVE FRANKLIN LAKES NJ 07417

Business Address

Type: 4/A | Act: 34 | File No.: 001-14956 | Film No.: 13575289